国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Shewanella sp. Non-canonical purine NTP phosphatase (Shewmr4_0759) CSB-YP611009SAAN
CSB-EP611009SAAN
CSB-BP611009SAAN
CSB-MP611009SAAN
CSB-EP611009SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Cytochrome c-552 (nrfA) CSB-YP611010SAAN
CSB-EP611010SAAN
CSB-BP611010SAAN
CSB-MP611010SAAN
CSB-EP611010SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Phosphatidylserine decarboxylase proenzyme (psd) CSB-YP611011SAAN
CSB-EP611011SAAN
CSB-BP611011SAAN
CSB-MP611011SAAN
CSB-EP611011SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 4-hydroxybenzoate octaprenyltransferase (ubiA), partial CSB-YP611012SAAN
CSB-EP611012SAAN
CSB-BP611012SAAN
CSB-MP611012SAAN
CSB-EP611012SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Diaminopimelate epimerase (dapF) CSB-YP611013SAAN
CSB-EP611013SAAN
CSB-BP611013SAAN
CSB-MP611013SAAN
CSB-EP611013SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Molybdenum cofactor biosynthesis protein C (moaC) CSB-YP611014SAAN
CSB-EP611014SAAN
CSB-BP611014SAAN
CSB-MP611014SAAN
CSB-EP611014SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 30S ribosomal protein S13 (rpsM) CSB-YP611015SAAN
CSB-EP611015SAAN
CSB-BP611015SAAN
CSB-MP611015SAAN
CSB-EP611015SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 30S ribosomal protein S14 (rpsN) CSB-YP611016SAAN
CSB-EP611016SAAN
CSB-BP611016SAAN
CSB-MP611016SAAN
CSB-EP611016SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 50S ribosomal protein L22 (rplV) CSB-YP611017SAAN
CSB-EP611017SAAN
CSB-BP611017SAAN
CSB-MP611017SAAN
CSB-EP611017SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Elongation factor G 1 (fusA1), partial CSB-YP611018SAAN
CSB-EP611018SAAN
CSB-BP611018SAAN
CSB-MP611018SAAN
CSB-EP611018SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 50S ribosomal protein L11 (rplK) CSB-YP611019SAAN
CSB-EP611019SAAN
CSB-BP611019SAAN
CSB-MP611019SAAN
CSB-EP611019SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. tRNA 2-selenouridine synthase (selU) CSB-YP611020SAAN
CSB-EP611020SAAN
CSB-BP611020SAAN
CSB-MP611020SAAN
CSB-EP611020SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Imidazolonepropionase (hutI) CSB-YP611021SAAN
CSB-EP611021SAAN
CSB-BP611021SAAN
CSB-MP611021SAAN
CSB-EP611021SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Xaa-Pro dipeptidase (pepQ) CSB-YP611022SAAN
CSB-EP611022SAAN
CSB-BP611022SAAN
CSB-MP611022SAAN
CSB-EP611022SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Chromosomal replication initiator protein DnaA (dnaA) CSB-YP611023SAAN
CSB-EP611023SAAN
CSB-BP611023SAAN
CSB-MP611023SAAN
CSB-EP611023SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP611024SAAO
CSB-EP611024SAAO
CSB-BP611024SAAO
CSB-MP611024SAAO
CSB-EP611024SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. ATP synthase gamma chain (atpG) CSB-YP611025SAAO
CSB-EP611025SAAO
CSB-BP611025SAAO
CSB-MP611025SAAO
CSB-EP611025SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Formamidopyrimidine-DNA glycosylase (mutM) CSB-YP611026SAAO
CSB-EP611026SAAO
CSB-BP611026SAAO
CSB-MP611026SAAO
CSB-EP611026SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase (menD), partial CSB-YP611027SAAO
CSB-EP611027SAAO
CSB-BP611027SAAO
CSB-MP611027SAAO
CSB-EP611027SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. UPF0289 protein Shewmr7_3609 (Shewmr7_3609) CSB-YP611028SAAO
CSB-EP611028SAAO
CSB-BP611028SAAO
CSB-MP611028SAAO
CSB-EP611028SAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>